PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Oncology, Department of Medicine, Stanford University, Stanford, California.\', \'Program in Immunology, Stanford University School of Medicine, Stanford, California.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1158/2643-3230.BCD-21-0222
?:doi
?:hasPublicationType
?:journal
  • Blood cancer discovery
is ?:pmid of
?:pmid
?:pmid
  • 35015688
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all